Risk of thromboembolic disease in men with prostate cancer undergoing androgen deprivation therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Risk of thromboembolic disease in men with prostate cancer undergoing androgen deprivation therapy

Published:2015-11-19 Issue:3 Volume:118 Page:391-398
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

O'Farrell Sean¹²,Sandström Karin¹,Garmo Hans¹³,Stattin Pär⁴,Holmberg Lars¹²³⁵,Adolfsson Jan⁶⁷,Van Hemelrijck Mieke¹²⁸

Affiliation:

1. Division of Cancer Studies; Cancer Epidemiology Group; King's College London; London UK

2. NIHR Guy's and St Thomas’ NHS Foundation Trust; King's College London's Comprehensive Biomedical Research Centre; London UK

3. Regional Cancer Centre; Uppsala Örebro; Uppsala Sweden

4. Department of Surgical and Perioperative Sciences, Urology and Andrology; Umeå University; Umeå Sweden

5. Department of Surgical Sciences; Uppsala University; Uppsala Sweden

6. Department of Clinical Science, Intervention and Technology; Karolinska Institutet; Stockholm Sweden

7. Swedish Council for Health Technology Assessment; Stockholm Sweden

8. Institute of Environmental Medicine; Karolinska Institute; Stockholm Sweden

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bju.13360/fullpdf

Reference33 articles.

1. Thromboembolic events following surgery for prostate cancer;Van Hemelrijck;Eur Urol,2013

2. Risk of thromboembolic diseases in men with prostate cancer: results from the population-based PCBaSe Sweden;Van Hemelrijck;Lancet Oncol,2010

3. Venous thromboembolism in the patient with cancer: focus on burden of disease and benefits of thromboprophylaxis;Lyman;Cancer,2011

4. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study;Heit;Arch Intern Med,2000

5. Pelvic lymph node dissection is associated with symptomatic venous thromboembolism risk during laparoscopic radical prostatectomy;Eifler;J Urol,2011

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thromboembolic risk in prostate cancer patients treated with PARP inhibitors: A systematic review and meta-analysis;Critical Reviews in Oncology/Hematology;2024-06

2. PDIA2 has a dual function in promoting androgen deprivation therapy induced venous thrombosis events and castrate resistant prostate cancer progression;Oncogene;2024-04-08

3. Determining the association of rurality and cardiovascular disease among prostate cancer survivors;Urologic Oncology: Seminars and Original Investigations;2023-10

4. Androgen-deprivation therapy with leuprolide increases abdominal adiposity without causing cardiac dysfunction in middle-aged male mice: effect of sildenafil;American Journal of Physiology-Regulatory, Integrative and Comparative Physiology;2023-04-01

5. Cardiovascular outcomes after curative prostate cancer treatment: A population-based cohort study;Frontiers in Oncology;2023-03-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3